Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Debra Ainge

- PMLiVE

Q&A: Kate Pain

Gemma Jones interviews Pfizer's digital marketing lead

- PMLiVE

Cancer disruptor F Star names next CEO

Dr Eliot Forster takes reins from Dr John Haurum

- PMLiVE

US says medicine ads should include list prices

Hopes the proposal will encourage lower prescription drug prices

- PMLiVE

UK pharma leader warns on ‘untenable’ Brexit deal

Draft agreement is a major step back for UK

Lucid Group are shortlisted in three different categories at this year’s PMEA programme

Lucid’s talent for working together with their clients to create magical programmes is clear to see as they celebrate three of their campaigns making the 2018 PMEA finals, well as...

Lucid Group Communications Limited

- PMLiVE

Tackling a formidable foe

Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis

- PMLiVE

Cancer care – the power of new technologies

With patient numbers set to soar, how can we make a difference?

- PMLiVE

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

Panel voted 10 to 3 in favour of the treatment

- PMLiVE

New leader at Medivir after setbacks

Christine Lind departs Swedish biotech

Natasha 2

Porterhouse Medical Group boosts its scientific services team with two new appointments

The Porterhouse Medical Group is delighted to welcome Tony Ferrar to our scientific services team based in Reading.With a passion for science, Tony has over 12 years of experience in...

Porterhouse Medical Group

- PMLiVE

Redefining communications excellence

How to be heard in today’s multichannel, multistakeholder, multimedia world

- PMLiVE

AstraZeneca: building a new ‘open innovation’ pharma company

The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links